Repository logo
 
Publication

What Happens to Non-Responders in Cardiac Resynchronization Therapy?

dc.contributor.authorRio, P
dc.contributor.authorOliveira, MM
dc.contributor.authorCunha, PS
dc.contributor.authorNogueira da Silva, M
dc.contributor.authorBranco, LM
dc.contributor.authorGalrinho, A
dc.contributor.authorSoares, R
dc.contributor.authorFeliciano, J
dc.contributor.authorPimenta, R
dc.contributor.authorCruz Ferreira, R
dc.date.accessioned2018-01-09T15:53:45Z
dc.date.available2018-01-09T15:53:45Z
dc.date.issued2017-12
dc.description.abstractINTRODUCTION AND OBJECTIVES: Left ventricular reverse remodeling (LVRR) is strongly related to the long-term prognosis of patients undergoing cardiac resynchronization therapy (CRT). The aim of this study was to assess the long-term clinical outcome of patients without LVRR at six months after CRT implantation and to determine the prognostic impact of clinical response in this population. METHODS: We analyzed 178 consecutive patients who underwent successful CRT device implantation (age 64±11 years; 69% male; 89% in New York Heart Association [NYHA] functional class III; 35% with ischemic cardiomyopathy). Clinical status and echocardiographic parameters were determined before and six months after CRT implantation. We identified those without criteria for LVRR (≥10% increase in left ventricular ejection fraction with ≥15% reduction in left ventricular end-systolic diameter compared to baseline). Clinical responders were defined by a sustained improvement of at least one NYHA functional class. RESULTS: At six-month assessment after CRT, 109 (61%) patients showed LVRR. During a mean follow-up of 56±21 months, 47 (26%) patients died, with higher mortality in the group without LVRR (36% vs. 20%, p=0.023). Clinical response was greater in patients with LVRR (88% vs. 55%, p<0.001). In patients without LVRR, clinical response to CRT was the strongest independent predictor of survival (hazard ratio: 0.120; 95% confidence interval: 0.039-0.366; p<0.001). CONCLUSION: Although patients without LVRR six months after CRT implantation had a worse prognosis, with higher all-cause mortality, clinical response can be an independent predictor of survival in this population.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationRev Port Cardiol. 2017 Dec;36(12):885-892pt_PT
dc.identifier.doi10.1016/j.repc.2017.02.017pt_PT
dc.identifier.urihttp://hdl.handle.net/10400.17/2839
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherElsevier Españapt_PT
dc.subjectHSM CARpt_PT
dc.subjectCardiac Resynchronization Therapypt_PT
dc.subjectDefibrillators, Implantablept_PT
dc.subjectHeart Failure/therapypt_PT
dc.subjectRetrospective Studiespt_PT
dc.subjectTime Factors
dc.subjectTreatment Failure
dc.titleWhat Happens to Non-Responders in Cardiac Resynchronization Therapy?pt_PT
dc.title.alternativeO Que Acontece aos Não Respondedores na Terapia de Ressincronização Cardíaca?pt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.endPage892pt_PT
oaire.citation.issue12pt_PT
oaire.citation.startPage885pt_PT
oaire.citation.titleRevista Portuguesa de Cardiologia (English Edition)pt_PT
oaire.citation.volume36pt_PT
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
RPC 2017 What happens.pdf
Size:
700.69 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:

Collections